Montelukast 10mg

DRUG9 trials

Conditions

AsthmaAsthma and Allergic RhinitisAtherosclerosis of ArteryCOVID-19Food-drug InteractionLower Limb IschemiaObesity; Endocrine; Diabetes Type 2Peripheral Arterial Disease

Early Phase 1

Investigation the Safety and Efficacy of The Antileukotriene Agents, Montelukast, as Adjuvant Therapy in Obese Patients With Type 2 Diabetes Mellitus

CompletedNCT04075110

Sadat City UniversityObesity; Endocrine; Diabetes Type 2

Start: 2019-07-01End: 2023-04-10Updated: 2023-04-11

Phase 2

Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily

CompletedNCT01147744

GlaxoSmithKlineAsthma

Start: 2010-06-28End: 2011-10-06Updated: 2017-10-02

Effect of Pineapple Juice on the Pharmacokinetics of Celecoxib and Montelukast in Humans

CompletedNCT04374981

Damanhour UniversityFood-drug Interaction

Start: 2019-07-01End: 2019-12-01Updated: 2020-05-05

The Covid-19 Outpatient Symptom Montelukast Oximetry Trial

NCT04389411

McGill UniversityCOVID-19

Start: 2022-11-01End: 2025-02-28Target: 250Updated: 2022-07-25

Phase 3

Montelukast for Patients With Obstructive Sleep Apnea Syndrome

TerminatedNCT03545997

University Hospital, GrenobleSleep Apnea, Obstructive

Start: 2019-11-29End: 2020-03-20Updated: 2021-02-17

Cysteinyl Leukotriene Antagonist in Atherosclerosis Inhibition in Patients After Endovascular Treatment Due to Peripheral Arterial Disease

NCT04277702

Jagiellonian UniversityAtherosclerosis of Artery, Lower Limb Ischemia, Peripheral Arterial Disease +1

Start: 2020-05-31End: 2023-12-31Target: 200Updated: 2020-02-20

Phase 4

A Pilot Study to Determine the Feasibility and Utility of Implementing of the Full Scale TOM Trial

CompletedNCT01696214

University of California, San DiegoAsthma

Start: 2012-10-31End: 2016-11-30Updated: 2019-01-23

Efficacy of Co-administration of Bilastine and Montelukast in Patients With SARC and Asthma

CompletedNCT02761252

Menarini International Operations Luxembourg SAAsthma, Seasonal Allergic Rhinoconjunctivitis

Start: 2016-04-13End: 2016-11-24Updated: 2019-07-12

Role of Montelukast in Asthma and Allergic Rhinitis Patients

CompletedNCT03380975

ClinisionAsthma and Allergic Rhinitis

Start: 2018-08-28End: 2019-06-30Updated: 2020-01-03

Related Papers

Evaluating the safety and efficacy of the leukotriene receptor antagonist montelukast as adjuvant therapy in obese patients with type 2 diabetes mellitus: A double-blind, randomized, placebo-controlled trial

Frontiers in Pharmacology2023-04-119 citations

Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol.

2022-01-0610 citations

Efficacy, safety and tolerability of GSK2190915, a 5-lipoxygenase activating protein inhibitor, in adults and adolescents with persistent asthma: a randomised dose-ranging study.

2013-05-1723 citations